Atossa Therapeutics Inc Q2 Investor Summit Transcript
All right. We're going to go ahead and get started. Thanks, everybody, for coming. And I'm not sure if all of the microphone turned on kind of the spar. I'm Kyle Guse, I'm the CFO and General Counsel at Atossa. I'm going to tell you how we're going to cure breast cancer.
So Atossa is a NASDAQ-listed, SEC-combined company, so please read our SEC filings before making any investment in Atossa. So we are a clinical-stage biopharmaceutical company seeking to develop innovative medicines in areas of significant unmet medical need with the current focus on oncology, primarily breast cancer and infectious disease, primarily COVID-19. Also, most of time talking about the breast cancer part of our business. We're a small group, we can make this interactive, if you like. If you have questions, feel free to interrupt as we go forward here.
So first, let me give you an overview of the company. On the breast cancer side of the business, we're developing a small molecule called Endoxifen, and we're developing this in a couple of
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
